Patents by Inventor Mitsukiyo Fujii

Mitsukiyo Fujii has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTRACT POWDER OF INDIGO PLANT, AND ITS PREPARATION AND USES
    Publication number: 20100034757
    Abstract: The present invention has objects to provide an extract powder of indigo plant, which has a relatively low hygroscopicity, satisfactory fluidability, and improved storage stability; a process thereof; and a composition incorporated with the extract powder. The objects are solved by a process for producing an extract powder of indigo plant, which comprises incorporating a partial starch hydrolyzate with a dextrose equivalent of 10.2 or lower into one part by weight, on a dry solid basis, of an indigo plant extract contained in a liquid extract of indigo plant in an amount of not lower than 0.25 part by weight but not higher than 5 parts by weight, on a dry solid basis, and drying the resulting mixture; an extract powder of indigo plant prepared thereby; and a composition incorporated with the extract powder.
    Type: Application
    Filed: November 22, 2007
    Publication date: February 11, 2010
    Inventors: Mitsukiyo Fujii, Shimpei Ushio, Kanso Iwaki, Fumiyo Kyono
  • Protein which induces interferon-&ggr; production by immunocompetent cell
    Patent number: 6441138
    Abstract: A protein of human cell origin, which induces the IFN-&ggr; production by immunocompetent cells and has the amino acid sequence of SEQ ID NO:1 near at the N-terminus. It can be produced from human cells such as lymphoblasts, lymphocytes, monoblasts, monocytes, myeloblasts, myelocytes, granulocytes and macrophages, and used for preventing and/or treating IFN-&ggr; susceptive diseases.
    Type: Grant
    Filed: January 3, 2001
    Date of Patent: August 27, 2002
    Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
    Inventors: Kenji Akita, Yoshiyuki Nukada, Mitsukiyo Fujii, Tadao Tanimoto, Masashi Kurimoto
  • Process for producing a pharmaceutical composition containing a protein which induces interferon-&ggr; production by an immunocompetent cell
    Patent number: 6403079
    Abstract: A protein of human cell origin, which induces the IFN-&ggr; production by immunocompetent cells and has the amino acid sequence of SEQ ID NO:1 near at the N-terminus. It can be produced from human cells such as lymphoblasts, lymphocytes, monoblasts, monocytes, myeloblasts, myelocytes, granulocytes and macrophages, and used for preventing and/or treating IFN-&ggr; susceptive diseases.
    Type: Grant
    Filed: March 29, 2001
    Date of Patent: June 11, 2002
    Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
    Inventors: Kenji Akita, Yoshiyuki Nukada, Mitsukiyo Fujii, Tadao Tanimoto, Masashi Kurimoto
  • Protein which induces interferon-gamma production by immunocompetent cell
    Publication number: 20010018212
    Abstract: A protein of human cell origin, which induces the IFN-&ggr; production by immunocompetent cells and has the amino acid sequence of SEQ ID NO:1 near at the N-terminus. It can be produced from human cells such as lymphoblasts, lymphocytes, monoblasts, monocytes, myeloblasts, myelocytes, granulocytes and macrophages, and used for preventing and/or treating IFN-&ggr; susceptive diseases.
    Type: Application
    Filed: January 3, 2001
    Publication date: August 30, 2001
    Applicant: KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO
    Inventors: Kenji Akita, Yoshiyuki Nukada, Mitsukiyo Fujii, Tadao Tanimoto, Masashi Kurimoto
  • Protein which induces interferon-gamma production by immunocompetent cell
    Patent number: 6242255
    Abstract: A protein of human cell origin, which induces the IFN-&ggr; production by immunocompetent cells and has the amino acid sequence of SEQ ID NO:1 near or at the N-terminus. It can be produced from human cells such as lymphoblasts, lymphocytes, monoblasts, monocytes, myeloblasts, myelocytes, granulocytes and macrophages, and used for preventing and/or treating IFN-&ggr; susceptive diseases.
    Type: Grant
    Filed: April 8, 1997
    Date of Patent: June 5, 2001
    Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kegaku Kenkyujo
    Inventors: Kenji Akita, Yoshiyuki Nukada, Mitsukiyo Fujii, Tadao Tanimoto, Masashi Kurimoto